Combined surgery for ischemic cardiomyopathy: report of a case

Susumu Ishikawa1, Keisuke Ueda, Akio Kawasaki

  • 1Department of Surgery, Cardiovascular Division, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan. ishikawa@med.teikyo-u.ac.jp

Journal of Cardiology
|July 22, 2008
PubMed

Insights

This study shows that combined surgical treatment can improve outcomes for patients with severe ischemic cardiomyopathy. A 65-year-old patient experienced a good quality of life two years post-surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Severe ischemic cardiomyopathy presents complex challenges, often involving multi-vessel coronary artery disease, mitral valve regurgitation, and left ventricular dysfunction.
  • Patients with catecholamine-dependent ischemic cardiomyopathy require advanced therapeutic strategies due to disease severity and limited treatment options.

Observation:

  • A 65-year-old female patient with catecholamine-dependent ischemic cardiomyopathy presented with severe triple vessel coronary artery disease, severe mitral valve regurgitation, and significant left ventricular (LV) dilatation with low ejection fraction.

Findings:

  • The patient underwent successful combined surgical procedures including coronary artery bypass grafting (CABG) with four distal anastomoses, mitral valve plasty using an original papillary muscle application method, LV volume reduction via an overlapping technique, and biventricular pacing.
  • The postoperative course was uneventful, with the patient demonstrating a good quality of life two years after the complex surgical intervention.

Implications:

  • Active combined surgical interventions offer a promising approach for improving clinical outcomes and long-term quality of life in patients suffering from severe ischemic cardiomyopathy.
  • This case highlights the potential benefits of comprehensive surgical management, integrating revascularization, valve repair, ventricular reconstruction, and pacing in a single operative session for complex cardiac conditions.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...